Kilitch Drugs (India) fundamental analysis

KILITCH

310.6

17.15 (-5.23%)
Last updated on 13 Mar, 2026 | 15:55 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Kilitch Drugs (India) Fundamentals

P/E Ratio

20.95

P/B Ratio

2.02

Div. Yield

0

Sector P/E

59.54

Sector P/B

2.65

Sec. Div. Yield

0.59

Kilitch Drugs (India) Fundamentals is currently trading with a P/E Ratio of 20.95, compared to the sector average of 59.54. Its P/B Ratio stands at 2.02, while the sector’s is 2.65. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.59%.

Kilitch Drugs (India) Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Good

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Average

On its scorecard, Kilitch Drugs (India) reflects: Price – Attractive, Growth – Good, Quality – Poor, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost